1. 1. Thiele J, Kvasnicka HM, Orazi A, Tefferi A, Birgegard G, Barbui T. Polycythaemia vera. In: Swerdlow SH, Campo E, Harris NL (eds). WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues, Vol 4. Lyon, IARC Press, 2017.
2. Monoclonal B-cell lymphocytosis (MBL): biology, natural history and clinical management;Shanafelt;Leukemia,2010
3. 3. Kodali S, Chen C, Rathnasabapathy C, Wang JC. JAK2 mutation in a patient with CLL with coexistent myeloproliferative neoplasm (MPN). Leuk Res 2009;33:e236-e239.
4. Polycythemia vera: stem-cell and probable clonal origin of the disease;Adamson;N Engl J Med,1976
5. Evidence that the JAK2 G1849T (V617F) mutation occurs in a lymphomyeloid progenitor in polycythemia vera and idiopathic myelofibrosis;Delhommeau;Blood,2007